Cogent Communications Holdings, Inc. ("Cogent") today announced service revenue of $247.0 million for the three months ended March 31, 2025, a decrease of 2.1% from the three months ended December 31, ...

Q32 Bio Inc. ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today reported financial ...